Results 231 to 240 of about 633,561 (259)
Some of the next articles are maybe not open access.
Treatment-Free Remission in Patients With Chronic Myeloid Leukaemia
Nature Reviews Clinical Oncology, 2020David Ross, Timothy Hughes
exaly
Inqovi for Acute Myeloid Leukemia
The Medical Letter on Drugs and TherapeuticsThe FDA has approved Inqovi (Taiho Oncology), a fixed-dose combination of the nucleoside metabolic inhibitor decitabine and the cytidine deaminase inhibitor cedazuridine, for use in combination with venetoclax (Venclexta, and generics) for oral treatment of newly diagnosed acute myeloid leukemia (AML) in adults who are ≥75 years old or who have ...
openaire +2 more sources
Epigenetics in Acute Myeloid Leukemia
Medical Epigenetics, 2016Carmela Dell'Aversana, Lucia Altucci
exaly
The Difficult Problem of Acute Myeloid Leukemia in the Older Adult
Ca-A Cancer Journal for Clinicians, 2002Richard M Stone
exaly
Single-Cell Mutation Analysis of Clonal Evolution in Myeloid Malignancies
Nature, 2020Ahmet Zehir, Kelly Bolton, Aaron Viny
exaly
Minimal Residual Disease in Acute Myeloid Leukaemia
Nature Reviews Clinical Oncology, 2013Christopher S Hourigan, Judith E Karp
exaly
Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: Which, When, for Whom?
Nature Reviews Clinical Oncology, 2017Gianantonio Rosti +2 more
exaly
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer
Cell, 2020Lei Zhang, Yao He, Shan Wang
exaly

